PL
PL · PL · PL-100488523
Orserdu
ATC L02BA04
Last synced from URPL (Poland) on
Identification
ManufacturerStemline Therapeutics B.V.
CountryPL (PL)
ATC codeL02BA04
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin09120113620283
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "345 mg",
"packaging": "09120113620283 ¦ Rpz ¦ EU/1/23/1757/002 ¦ 151707\n28 tabl.",
"substance": "Elacestranti dihydrochloridum 345 mg",
"common_name": "Elacestranti dihydrochloridum",
"pl_product_id": "100488523",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L02BA04.
- GBKorserdu 345mg tabletsMenarini Stemline UK Ltd
- GBKorserdu 86mg tabletsMenarini Stemline UK Ltd
- PLOrserduStemline Therapeutics B.V.
- 🇨🇭OrserduStemline Therapeutics Switzerland GmbH
- ISOrserduStemline Therapeutics B.V.
- ISOrserduStemline Therapeutics B.V.
- 🇨🇭OrserduStemline Therapeutics Switzerland GmbH
- DKORSERDUStemline Therapeutics B.V.
Access this data programmatically
Query Orserdu and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.